Founded in 2023, Valendo Health was fostered under startup incubator Redesign Health. It offers a population health management platform for independent endocrinologists, including expertise, technology, and data tools to optimize clinical capacity and streamline operations.
The company offers a three-phase approach through which it provides telehealth, remote monitoring, endocrinology software, and analytics, within a value-based care framework to enhance diabetes care. The company aims to increase revenue for care providers through contracts that reward improved patient outcomes and cost efficiencies, aligning financial incentives with health outcomes.
Key customers and partnerships
The company has collaborated with healthcare providers Cecelia Health and Advanced Metabolic Care & Research to offer Valendo Health’s platform and improve diabetes care delivery.
Funding and financials
In January 2024, the company launched from stealth and raised USD 4 million in seed funding.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.